Cargando…

Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: a threat to filariasis elimination status?

BACKGROUND: Post-mass drug administration (MDA) surveillance during the lymphatic filariasis (LF) elimination program in Sri Lanka, revealed the re-emergence of brugian filariasis after four decades. This study was done with the objectives of investigating the epidemiology and age-specific vulnerabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallawarachchi, Chandana H., Nilmini Chandrasena, T. G. A., Premaratna, Ranjan, Mallawarachchi, S. M. N. S. M., de Silva, Nilanthi R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789669/
https://www.ncbi.nlm.nih.gov/pubmed/29378620
http://dx.doi.org/10.1186/s13071-018-2649-3
_version_ 1783296329434267648
author Mallawarachchi, Chandana H.
Nilmini Chandrasena, T. G. A.
Premaratna, Ranjan
Mallawarachchi, S. M. N. S. M.
de Silva, Nilanthi R.
author_facet Mallawarachchi, Chandana H.
Nilmini Chandrasena, T. G. A.
Premaratna, Ranjan
Mallawarachchi, S. M. N. S. M.
de Silva, Nilanthi R.
author_sort Mallawarachchi, Chandana H.
collection PubMed
description BACKGROUND: Post-mass drug administration (MDA) surveillance during the lymphatic filariasis (LF) elimination program in Sri Lanka, revealed the re-emergence of brugian filariasis after four decades. This study was done with the objectives of investigating the epidemiology and age-specific vulnerability to infection. Surveillance was done using night blood smears (NBS) and the Brugia rapid test (BRT), to detect microfilaria (MF) and anti-Brugia IgG4 antibodies in blood samples collected from an age-stratified population enrolled from two high-risk study areas (SA)s, Pubudugama and Wedamulla in the Gampaha District. The periodicity of the re-emergent Brugia spp. was characterized by quantitative estimation of MF in blood collected periodically over 24 h using nucleopore-membrane filtration method. RESULTS: Of 994 participants [Pubudugama 467 (47.9%) and Wedamulla 527 (53%)] screened by NBS, two and zero cases were positive for MF at Pubudugama (MF rate, 0.43) and Wedamulla (MF rate, 0), respectively, with an overall MF rate of 0.2. Of the two MF positives, one participant had a W. bancrofti while the other had a Brugia spp. infection. Of 984 valid BRT test readings [Pubudugama (n = 461) and Wedamulla (n = 523)], two and seven were positive for anti-brugia antibodies by BRT at Pubudugama (antibody rate 0.43) and Wedamulla (antibody rate 1.34), respectively, with an overall antibody rate of 0.91. Both MF positives detected from SAs and two of three other Brugia spp. MF positives detected at routine surveillance by the National Anti-Filariasis Campaign (AFC) tested negative by the BRT. Association of Brugia spp. infections with age were not evident due to the low case numbers. MF was observed in the peripheral circulation throughout the day (subperiodic) with peak counts occurring at 21 h indicating nocturnal sub-periodicity. CONCLUSIONS: There is the low-level persistence of bancroftian filariasis and re-emergence of brugian filariasis in the Gampaha District, Sri Lanka. The periodicity pattern of the re-emergent Brugia spp. suggests a zoonotic origin, which causes concern as MDA may not be an effective strategy for control. The importance of continuing surveillance is emphasized in countries that have reached LF elimination targets to sustain programmatic gains.
format Online
Article
Text
id pubmed-5789669
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57896692018-02-08 Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: a threat to filariasis elimination status? Mallawarachchi, Chandana H. Nilmini Chandrasena, T. G. A. Premaratna, Ranjan Mallawarachchi, S. M. N. S. M. de Silva, Nilanthi R. Parasit Vectors Research BACKGROUND: Post-mass drug administration (MDA) surveillance during the lymphatic filariasis (LF) elimination program in Sri Lanka, revealed the re-emergence of brugian filariasis after four decades. This study was done with the objectives of investigating the epidemiology and age-specific vulnerability to infection. Surveillance was done using night blood smears (NBS) and the Brugia rapid test (BRT), to detect microfilaria (MF) and anti-Brugia IgG4 antibodies in blood samples collected from an age-stratified population enrolled from two high-risk study areas (SA)s, Pubudugama and Wedamulla in the Gampaha District. The periodicity of the re-emergent Brugia spp. was characterized by quantitative estimation of MF in blood collected periodically over 24 h using nucleopore-membrane filtration method. RESULTS: Of 994 participants [Pubudugama 467 (47.9%) and Wedamulla 527 (53%)] screened by NBS, two and zero cases were positive for MF at Pubudugama (MF rate, 0.43) and Wedamulla (MF rate, 0), respectively, with an overall MF rate of 0.2. Of the two MF positives, one participant had a W. bancrofti while the other had a Brugia spp. infection. Of 984 valid BRT test readings [Pubudugama (n = 461) and Wedamulla (n = 523)], two and seven were positive for anti-brugia antibodies by BRT at Pubudugama (antibody rate 0.43) and Wedamulla (antibody rate 1.34), respectively, with an overall antibody rate of 0.91. Both MF positives detected from SAs and two of three other Brugia spp. MF positives detected at routine surveillance by the National Anti-Filariasis Campaign (AFC) tested negative by the BRT. Association of Brugia spp. infections with age were not evident due to the low case numbers. MF was observed in the peripheral circulation throughout the day (subperiodic) with peak counts occurring at 21 h indicating nocturnal sub-periodicity. CONCLUSIONS: There is the low-level persistence of bancroftian filariasis and re-emergence of brugian filariasis in the Gampaha District, Sri Lanka. The periodicity pattern of the re-emergent Brugia spp. suggests a zoonotic origin, which causes concern as MDA may not be an effective strategy for control. The importance of continuing surveillance is emphasized in countries that have reached LF elimination targets to sustain programmatic gains. BioMed Central 2018-01-29 /pmc/articles/PMC5789669/ /pubmed/29378620 http://dx.doi.org/10.1186/s13071-018-2649-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mallawarachchi, Chandana H.
Nilmini Chandrasena, T. G. A.
Premaratna, Ranjan
Mallawarachchi, S. M. N. S. M.
de Silva, Nilanthi R.
Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: a threat to filariasis elimination status?
title Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: a threat to filariasis elimination status?
title_full Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: a threat to filariasis elimination status?
title_fullStr Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: a threat to filariasis elimination status?
title_full_unstemmed Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: a threat to filariasis elimination status?
title_short Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: a threat to filariasis elimination status?
title_sort human infection with sub-periodic brugia spp. in gampaha district, sri lanka: a threat to filariasis elimination status?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789669/
https://www.ncbi.nlm.nih.gov/pubmed/29378620
http://dx.doi.org/10.1186/s13071-018-2649-3
work_keys_str_mv AT mallawarachchichandanah humaninfectionwithsubperiodicbrugiasppingampahadistrictsrilankaathreattofilariasiseliminationstatus
AT nilminichandrasenatga humaninfectionwithsubperiodicbrugiasppingampahadistrictsrilankaathreattofilariasiseliminationstatus
AT premaratnaranjan humaninfectionwithsubperiodicbrugiasppingampahadistrictsrilankaathreattofilariasiseliminationstatus
AT mallawarachchismnsm humaninfectionwithsubperiodicbrugiasppingampahadistrictsrilankaathreattofilariasiseliminationstatus
AT desilvanilanthir humaninfectionwithsubperiodicbrugiasppingampahadistrictsrilankaathreattofilariasiseliminationstatus